Viral load testing among pregnant women living with HIV in Mutare district of Manicaland province, Zimbabwe
Open Access
- 16 November 2022
- journal article
- research article
- Published by Springer Nature in AIDS Research and Therapy
- Vol. 19 (1) , 1-11
Abstract
Background: Viral load (VL) monitoring of pregnant women living with HIV (PWLHIV) and antiretroviral therapy (ART) may contribute to lowering the risk of vertical transmission of HIV. The aims of this study were to assess the uptake of HIV VL testing among PWLHIV at entry to the prevention-of-mother-to-child transmission (PMTCT) services and identify facilitatory factors and barriers to HIV VL access.Methods: A retrospective, cross-sectional study was conducted at 15 health facilities in Mutare district, Manicaland Province, Zimbabwe from January to December 2018. This analysis was complemented by prospective interviews with PWLHIV and health care providers between October 2019 and March 2020. Quantitative data were analysed using descriptive and inferential statistical methods. Risk factors were evaluated using multivariate logistic regression. Open-ended questions were analysed and recurring and shared experiences and perceptions of PWLHIV and health care providers identified.Results: Among 383 PWLHIV, enrolled in antenatal care (ANC) and receiving ART, only 121 (31.6%) had a VL sample collected and 106 (88%) received their results.Among these 106 women, 93 (87.7%) had a VL < 1000 copies/mL and 77 (73%) a VL < 50 copies/mL. The overall median duration from ANC booking to VL sample collection was 87 (IQR, 7–215) days. The median time interval for the return of VL results from date of sample collection was 14 days (IQR, 7–30). There was no significant difference when this variable was stratified by time of ART initiation. VL samples were significantly less likely to be collected at local authority compared to government facilities (aOR = 0.28; 95% CI 0.16–0.48). Barriers to VL testing included staff shortages, non-availability of consumables and sub-optimal sample transportation. Turnaround time was prolonged by the manual results feedback system.Conclusions and recommendation: The low rate of HIV VL testing among PWLHIV in Mutare district is a cause for concern. To reverse this situation, the Ministry of Health should consider interventions such as disseminating antiretroviral guidelines and policies electronically, conducting regular PMTCT mentorship for clinical staff members, and utilising point of care testing and telecommunication devices like mHealth to increase uptake of VL testing and improve results turnaround time.Keywords
This publication has 44 references indexed in Scilit:
- Detectable Viral Load in Late Pregnancy among Women in the Rwanda Option B+ PMTCT Program: Enrollment Results from the Kabeho StudyPLOS ONE, 2016
- Progress with Scale-Up of HIV Viral Load Monitoring — Seven Sub-Saharan African Countries, January 2015–June 2016MMWR. Morbidity and Mortality Weekly Report, 2016
- Point-of-Care Cepheid Xpert HIV-1 Viral Load Test in Rural African Communities Is Feasible and ReliableJournal of Clinical Microbiology, 2016
- Scale-up of Routine Viral Load Testing in Resource-Poor Settings: Current and Future Implementation Challenges: Table 1.Clinical Infectious Diseases, 2016
- No Perinatal HIV-1 Transmission From Women With Effective Antiretroviral Therapy Starting Before ConceptionClinical Infectious Diseases, 2015
- Risks and benefits of lifelong antiretroviral treatment for pregnant and breastfeeding womenCurrent Opinion in HIV and AIDS, 2013
- Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in AfricaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
- Factors Associated with Mother‐to‐Child Transmission of HIV‐1 Despite a Maternal Viral Load <500 Copies/mL at Delivery: A Case‐Control Study Nested in the French Perinatal Cohort (EPF‐ANRS CO1)Clinical Infectious Diseases, 2010
- Perinatal Transmission of Human Immunodeficiency Virus Type 1 by Pregnant Women with RNA Virus Loads <1000 Copies/mLThe Journal of Infectious Diseases, 2001
- Maternal Levels of Plasma Human Immunodeficiency Virus Type 1 RNA and the Risk of Perinatal TransmissionNew England Journal of Medicine, 1999